About Merck Sharp & Dohme
Merck Sharp & Dohme is a company based in Kenilworth (United States) founded in 1890 was acquired by Onyx Equities in February 2023.. Merck Sharp & Dohme has completed 2 acquisitions, including EyeBio and Merck. Merck Sharp & Dohme offers products and services including Vaccines, Medicines, and Clinical Trials. Merck Sharp & Dohme operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Kenilworth, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Merck & Co., Inc., Rahway, Nj, Usa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$12.03 K (USD), Grant
Oct 01, 2019
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
EyeBio
& 1 more
-
Acquired by
Onyx Equities
(Feb 21, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merck Sharp & Dohme
Merck Sharp & Dohme offers a comprehensive portfolio of products and services, including Vaccines, Medicines, and Clinical Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for preventing infectious diseases through immunization.
Treatments for conditions like oncology and immunology.
Platforms for testing new health solutions and innovations.
Unlock access to complete
Unlock access to complete
Leadership Team
442 people
Software Development Team
251 people
Product Management Team
73 people
Sales and Marketing
73 people
Senior Team
64 people
Data Analysis and Operations Team
63 people
Operations Team
54 people
Finance and Accounting
30 people
Unlock access to complete
Funding Insights of Merck Sharp & Dohme
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $12,030
-
First Round
First Round
(01 Apr 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Grant - Merck Sharp & Dohme | Valuation |
investors |
|
| Apr, 2017 | Amount | Grant - Merck Sharp & Dohme | Valuation |
investors |
|
| Apr, 2015 | Amount | Grant - Merck Sharp & Dohme | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Merck Sharp & Dohme
Merck Sharp & Dohme has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Machine Investment Group and Onyx Equities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Invests in middle market real estate opportunities, distressed debt, and special situations.
|
Founded Year | Domain | Location | |
|
Acquires and manages under-performing commercial properties with full service platform.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Merck Sharp & Dohme
Merck Sharp & Dohme has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include EyeBio and Merck. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies for ophthalmological diseases are developed to restore vision.
|
2021 | ||||
|
T-cell antibodies are developed against hematologic and solid tumor targets.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Merck Sharp Dohme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Merck Sharp & Dohme Comparisons
Competitors of Merck Sharp & Dohme
Merck Sharp & Dohme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Merck Sharp & Dohme
Frequently Asked Questions about Merck Sharp & Dohme
When was Merck Sharp & Dohme founded?
Merck Sharp & Dohme was founded in 1890 and raised its 1st funding round 125 years after it was founded.
Where is Merck Sharp & Dohme located?
Merck Sharp & Dohme is headquartered in Kenilworth, United States.
What does Merck Sharp & Dohme do?
Merck Sharp Dohme was founded in 1890 and is headquartered in Kenilworth, United States. Operations focus on pharmaceutical development within the healthcare sector. A pipeline of therapies is maintained, including MK-1439A for HIV treatment, V184 vaccine for chikungunya virus, and V937 for breast cancer. Additional portfolios address diabetes, infectious diseases, and oncology, with research extending to various therapeutic areas.
Who are the top competitors of Merck Sharp & Dohme?
Merck Sharp & Dohme's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Merck Sharp & Dohme offer?
Merck Sharp & Dohme offers Vaccines, Medicines, and Clinical Trials.
How many acquisitions has Merck Sharp & Dohme made?
Who are Merck Sharp & Dohme's investors?
Merck Sharp & Dohme has 3 investors. Key investors include European Union, Machine Investment Group, and Onyx Equities.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.